A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection

PHASE2TerminatedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

October 14, 2021

Study Completion Date

December 28, 2021

Conditions
Chronic Hepatitis B
Interventions
DRUG

ABI-H2158

3 X 100 mg tablets for oral administration

DRUG

Placebo

Sugar pill manufactured to mimic the ABI-H2158 tablets

DRUG

Entecavir (ETV)

0.5 mg tablet for oral administration

Trial Locations (44)

100

National Taiwan University Hospital, Taipei

333

Chang Gung Memorial Hospital (CGMH) - Linkou Branch, Taoyuan District

2010

St. Vincent's Hospital, Darlinghurst

2050

Royal Prince Alfred Hospital, Camperdown

2105

Auckland Clinical Studies, Auckland

2305

John Hunter Hospital, New Lambton

3004

Alfred Hospital, Melbourne

3050

Melbourne Health, Parkville

3065

St. Vincent's Hospital, Fitzroy

3240

Waikato Hospital, Hamilton

4120

Gallipoli Medical Research Foundation, Greenslopes

10016

NYU Langone Health, New York

10449

Mackay Memorial Hospital Taipei Branch, Taipei

11030

Northwell Health Center for Liver Disease, Manhasset

11355

New Discovery, LLC, Flushing

19107

Thomas Jefferson University, Philadelphia

21287

Johns Hopkins University, Baltimore

24253

Hallym University Chuncheon Sacred Heart Hospital, Chuncheon

33136

University of Miami/Schiff Center for Liver Diseases, Miami

44047

China Medical University Hospital, Taichung

49241

Pusan National University Hospital, Busan

50612

Pusan National University Yangsan Hospital, Yangsan

78215

American Research Corporation at the Texas Liver Institute, San Antonio

80756

Kaohsiung Medical University Hospital, Kaohsiung City

90020

Coalition of Inclusive Medicine, Los Angeles

91105

California Liver Research Institute, Pasadena

92105

Research and Education Inc., San Diego

94063

Stanford University Medical Center, Redwood City

94115

Quest Clinical Research, San Francisco

98104

University of Washington, Seattle

130021

The First Hospital of Jilin University, Changchun

400010

The Second Affliated Hospital of Chongqing Medical University, Chongqing

410008

Xiangya Hospital Central South University, Changsha

510515

Nanfang Hospital, Guangzhou

V6Z 2K5

(G.I.R.I.) GI Research Institute, Vancouver

M6H 3M1

Toronto Liver Centre, Toronto

Unknown

Guangzhou Eighth People's Hospital - Guangzhou Infectious Diseases Hospital, Guangzhou

Prince of Wales Hospital, Shatin

Queen Mary Hospital, Hong Kong

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

07061

SMG-SNU Boramae Medical Center, Seoul

SE5 9RS

King's College Hospital, London

Sponsors
All Listed Sponsors
lead

Assembly Biosciences

INDUSTRY

NCT04398134 - A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection | Biotech Hunter | Biotech Hunter